Director/PDMR Shareholding

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Tobias Hestler 

2  

Reason for the notification  

a)

Position/status

Chief Financial Officer - Person Discharging Managerial Responsibilities 

b)

Initial notification /Amendment

Initial Notification 

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Haleon plc 

b)

LEI

549300PSB3WWEODCUP19 

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

Nature of the transaction

Ordinary shares received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022. 

c)

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

10,464 

d)

Aggregated information

- Aggregated volume 

10,464 

- Price 

n/a 

e)

Date of the transaction

18 July 2022 

f)

Place of the transaction

London Stock Exchange 

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Keith Choy 

2  

Reason for the notification  

a)

Position/status

President, Asia Pacific - Person Discharging Managerial Responsibilities 

b)

Initial notification /Amendment

Initial Notification 

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Haleon plc 

b)

LEI

549300PSB3WWEODCUP19 

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

Nature of the transaction

Ordinary shares received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022. 

c)

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

17,864 

d)

Aggregated information

- Aggregated volume 

17,864 

- Price 

n/a 

e)

Date of the transaction

18 July 2022 

f)

Place of the transaction

London Stock Exchange 

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Bart Derde 

2  

Reason for the notification  

a)

Position/status

Chief Supply Chain Officer - Person Discharging Managerial Responsibilities 

b)

Initial notification /Amendment

Initial Notification 

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Haleon plc 

b)

LEI

549300PSB3WWEODCUP19 

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

Nature of the transaction

Ordinary shares received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022. 

c)

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

21,278

d)

Aggregated information

- Aggregated volume 

21,278 

- Price 

n/a 

e)

Date of the transaction

18 July 2022 

f)

Place of the transaction

London Stock Exchange 

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Amy Landucci 

2  

Reason for the notification  

a)

Position/status

Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities 

b)

Initial notification /Amendment

Initial Notification 

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Haleon plc 

b)

LEI

549300PSB3WWEODCUP19 

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

Nature of the transaction

Ordinary shares received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022. 

c)

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

17,994

d)

Aggregated information

- Aggregated volume 

17,994 

- Price 

n/a 

e)

Date of the transaction

18 July 2022 

f)

Place of the transaction

London Stock Exchange 

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Filippo Lanzi 

2  

Reason for the notification  

a)

Position/status

President, EMEA & LATAM - Person Discharging Managerial Responsibilities 

b)

Initial notification /Amendment

Initial Notification 

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Haleon plc 

b)

LEI

549300PSB3WWEODCUP19 

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

Nature of the transaction

Ordinary shares received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022. 

c)

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

44,376 

d)

Aggregated information

- Aggregated volume 

44,376 

- Price 

n/a 

e)

Date of the transaction

18 July 2022 

f)

Place of the transaction

London Stock Exchange 

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Franck Riot 

2  

Reason for the notification  

a)

Position/status

Chief R&D Officer - Person Discharging Managerial Responsibilities 

b)

Initial notification /Amendment

Initial Notification 

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Haleon plc 

b)

LEI

549300PSB3WWEODCUP19 

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

Nature of the transaction

Ordinary shares received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022. 

c)

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

1,376 

d)

Aggregated information

- Aggregated volume 

1,376 

- Price 

n/a 

e)

Date of the transaction

18 July 2022 

f)

Place of the transaction

London Stock Exchange 

1  

Details of the person discharging managerial responsibilities / person closely associated  

a)

Name

Tamara Rogers 

2  

Reason for the notification  

a)

Position/status

Chief Marketing Officer - Person Discharging Managerial Responsibilities 

b)

Initial notification /Amendment

Initial Notification 

3  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Haleon plc 

b)

LEI

549300PSB3WWEODCUP19 

4  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 

Identification code

GB00BMX86B70  

b)

Nature of the transaction

Ordinary shares received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022. 

c)

Price(s) and volume(s)

Price(s) 

Volume(s) 

n/a 

104 

d)

Aggregated information

- Aggregated volume 

104 

- Price 

n/a 

e)

Date of the transaction

18 July 2022 

f)

Place of the transaction

London Stock Exchange